Benzodiazepines and Related Sedatives
| Autor: | Kenneth L. Morford, Ximena A. Levander, Linda Peng |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
Male medicine.medical_specialty medicine.drug_class Substance-Related Disorders medicine.medical_treatment Physical dependence Designer Drugs Benzodiazepines Young Adult Neurobiology Detoxification medicine Humans Hypnotics and Sedatives Intensive care medicine Adverse effect Benzodiazepine Drug Tapering business.industry General Medicine Receptors GABA-A Discontinuation Substance Withdrawal Syndrome Cognitive behavioral therapy Quality of evidence Sedative Inactivation Metabolic Female medicine.symptom business |
| Zdroj: | The Medical clinics of North America. 106(1) |
| ISSN: | 1557-9859 |
| Popis: | Benzodiazepine and related sedative use has been increasing. There has been a growing number of unregulated novel psychoactive substances, including designer benzodiazepines. Benzodiazepines have neurobiological and pharmacologic properties that result in a high potential for misuse and physical dependence. Options for discontinuing long-term benzodiazepine use include an outpatient benzodiazepine taper or inpatient withdrawal management at a hospital or detoxification facility. The quality of evidence on medications for benzodiazepine discontinuation is overall low, whereas cognitive behavioral therapy has shown the most benefit in terms of behavioral treatments. Benzodiazepines may also have significant adverse effects, increasing the risk of overdose and death. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|